The Glaucoma Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Glaucoma Market?
The glaucoma market has seen robust growth in the past years. The market size is projected to expand from $7.76 billion in 2024 to $8.22 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Glaucoma Industry?
By 2029, the glaucoma market is expected to reach a size of $10.20 billion, growing at a compound annual growth rate (CAGR) of 5.5%.
Download Your Free Sample of the 2025 Glaucoma Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Glaucoma Market?
The key drivers in the glaucoma market are:
•Increased aging population and prevalence of glaucoma
•Growing demand for minimally invasive surgeries
•Rising prevalence of diabetes and hypertension
•Technological advancements in diagnostic and surgical devices along with the emergence of new drug treatments and combination therapies.
Global Market Segmentation: Identifying Major Glaucoma Industry Segments
The glaucoma market covered in this report is segmented –
1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types
2) By Diagnosis: Tonometry, Ophthalmoscopy, Perimetry, Gonioscopy
3) By Drug Class: Beta Blockers, Prostaglandins, Alpha Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Combination Drugs, Other Drug Classes
4) By Administration: Oral, Injections, Intravitreal, Other Administrations
5) By End-User: Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Open Angle Glaucoma: Primary Open Angle Glaucoma (POAG), Secondary Open Angle Glaucoma
2) By Angle Closure Glaucoma: Primary Angle Closure Glaucoma, Secondary Angle Closure Glaucoma
3) By Other Disease Types: Normal-Tension Glaucoma, Pigmentary Glaucoma, Pseudoexfoliative Glaucoma, Congenital Glaucoma
Pre-order the 2025 Glaucoma Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Glaucoma Market?
The key trends in the glaucoma market are:
•Advancements in diagnostic technologies are impacting the future of the market.
•The introduction of new drug treatments are setting new market trends.
•Technological innovations in surgical devices are emerging as a notable trend.
•The adoption of robotic surgeries is shaping the future trajectory of the market.
Who Are the Top Competitors & Leading Players in the Glaucoma Market?
Major players in the glaucoma market are:
• Roche Holding AG
• Merck & Co. Inc.
• AbbVie Inc.
• Novartis AG
• Teva Pharmaceuticals Industries Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Cipla Limited
• Bausch & Lomb Corp.
• Carl Zeiss Meditec
• Santen Pharmaceuticals Co. Ltd.
• Topcon Corporation
• Thea Laboratoires
• Corza Ophthalmology
• Lumenis Ltd.
• Alcon Inc.
• Viva BioInnovator
• Glaukos Corporation
• Iridex Corporation
• Nova Eye Medical Ltd.
• Renova Life Sciences Private Limited
• Qlaris Bio Inc.
• PolyActiva Pty Ltd.
• Nidek Co. Ltd.
• Haag-Streit AG
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the glaucoma market in 2024
